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When ethics and politics collide in donor-funded global health research  
By Katerini T. Storeng and Jennifer Palmer 
Introduction 
In this viewpoint, we share our experience of censorship in evaluation research for global health. Our 
story shows a broader trend of donors and implementing partners’ deliberate uses of ethical and 
methodological arguments to undermine essential research. In a context of chronic underfunding of 
universities and their growing dependence on donor-driven research grants, we propose several 
structural and cultural changes to prevent manipulation of research governance systems and to 
safeguard the independence of research. 
Censorship is a strong word. But what else can you call it when a donor that commissions a research-
based evaluation of one of its major global health programmes instructs the researchers to omit 
important results from their final report? Or puts pressure on them to change the tenor of their 
conclusions? Or when a staff member of an implementing partner being evaluated threatens the 
reputation of the researchers and their university if they publish negative findings?  
Such interference in any research process is antithetical to independence. Agencies commissioning 
evaluation research, which tends to have an immediate and practical use for decision-makers, often 
engage public health universities to study their programmes. They rely not only on universities’ 
methodological and subject area expertise but also on their strong systems of research ethics and 
governance, recognising that compliance with such systems is essential for ensuring that the evidence 
produced adheres to “the highest standards of integrity”1. However, current systems primarily protect 
vulnerable research subjects from powerful researchers and are ill equipped to deal with challenges 
when researchers are less powerful than research subjects. 
A case study of censorship 
We experienced some of the limitations of current systems in research ethics and governance within 
an evaluation of a programme funded by the United Kingdom’s Department for International 
Development (DFID). With a budget exceeding £140,000,000, the programme aimed to reduce deaths 
from unwanted pregnancies in 14 countries in Africa and Asia through policy and service delivery 
interventions.2 These were implemented by the leading international reproductive health NGOs Marie 
Stopes International (MSI) and Ipas. The evaluation research, commissioned by DFID, was carried out 
by an international, interdisciplinary consortium led by the London School of Hygiene and Tropical 
Medicine (LSHTM), with which we are affiliated.  
DFID considered the implementing NGOs “stakeholders” of the evaluation whose involvement was 
desirable “so long as the objectivity of the study is not compromised.”1 MSI and Ipas therefore had the 
opportunity to comment on our study protocol, broker our access to informants and documents, and 
preview research outputs for fact checking. DFID and the NGOs considered this important because of 
the “risks” the outputs might pose to the programme within socially conservative countries.  
In practice, staff at the NGOs’ headquarters used this stakeholder involvement to obstruct aspects of 
the evaluation in various ways, not least when, at the end of the contract, we sought to disseminate 
policy research findings to academic audiences. In addition to requesting changes to tone and content, 
they demanded that we anonymise their organisations and ideally, the target countries, claiming our 
findings could be “weaponized” by their political opponents to derail policy change. Other times, 
however, the NGOs simply stated they wanted to be unnamed because they disagreed with our 
“positions and conclusions”. 
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In addition to making these demands, senior NGO staff met with the Chair of the LSHTM’s ethics 
committee, which had approved the research protocol, to voice “concerns” that we had not followed 
appropriate procedures for obtaining informed consent. Later, in a coordinated move, three 
individuals from both MSI and Ipas retroactively withdrew consent for using their specific contributions 
in our research after our academic articles had already undergone favourable peer review.  
The accusations resulted in a thorough investigation by the university’s Research Governance and 
Integrity Office, charged with ensuring that researchers comply with relevant regulatory requirements, 
including ethical protocols. While under investigation, we withdrew scheduled conference 
presentations and halted our publications.  
The university concluded we had adhered to good research ethical principles, but that we must  
anonymise the NGOs because our protocol had promised to protect individuals’ identities and, “where 
appropriate”, that of their organisation. Although we had intended this clause to allow individuals to 
discuss sensitive issues without having to divulge their institutional affiliation, the ambiguity in this 
wording initially prompted the ethics committee to extend that protection to these powerful 
organisations. The practical consequence was to sanction the NGOs’ wish to control which findings we 
could make public.  
We felt that the NGOs had used the research ethics framework to censor our work, and therefore 
appealed the university’s decision. We argued that anonymising organisations and countries would 
make it impossible to substantiate our analysis and that the claim to harm was exaggerated, designed 
mainly to obstruct our publications. We also felt strongly that it was in the public interest to be 
transparent about the identity of recipients of public funds and about their programmatic practices, a 
principle that DFID has committed to publicly.1 
We also turned to senior staff at DFID to protect our independence, but they dismissed our request 
for a meeting, saying they could see no merit for DFID “to interfere in a ‘he said she said’ situation” 
and referred us back to the ethics committee.   
Eventually, we were able to publish one of the disputed academic articles3 after the Research 
Governance and Integrity Office concluded that we were not required to conceal the identities of the 
organisations being evaluated, provided that the data used came from public domain sources or 
participants who had not withdrawn consent.  
Many other findings, however, remain unpublished. The final evaluation report,4 published nearly 18 
months after its first submission, contains only a condensed summary of evaluation findings, while 
DFID annexed the detailed country policy analyses reports into sections that will remain internal. 
Meanwhile, partly due to the intimidating environment, other researchers have hesitated to publish 
full analyses that are ambivalent about the programme’s overall effectiveness. As a result, a substantial 
reservoir of learning generated by more than 20 academic researchers over a five-year period is not 
available to the public, including to implementers and external evaluators of the follow-on programme 
funded by DFID.  
A pattern of interference   
Although we present only one case study, similar dynamics play out between other public, private and 
philanthropic donors and researchers who undertake evaluations and other commissioned global 
health research.   
Numerous colleagues have described similar forms of interference at different stages of the research 
process, resulting in “tick-box evaluation” designed to please donors, reports that have been “shelved” 
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or “embargoed”, and “bartering” about which findings can be published. Often such interference is 
couched in the language of ethics; other times donors and their implementing partners attack the 
rigour of research methodology or discredit researchers’ interpretations as “naïve” to pressure them 
to suppress findings and analyses that cast programmatic strategies and outcomes in unfavourable 
light. 
Although some academics have gone public with their experiences, 5,6 most such cases remain 
unknown, which shows how demanding it is for individuals to confront strong institutional interests in 
the nexus between funders, NGOs and universities.7 For us, it would have been easier to acquiesce to 
the pressure we experienced. Being accused, in effect, of ethical malpractice was an ordeal, and by 
speaking out, we risk future funding, career progression, and co-optation by the anti-aid agenda. 
Such risks are pronounced within a landscape marked by chronic underfunding of universities and 
reliance on soft funding through short-term, donor-prioritised research projects, where the stated or 
tacit threat of withdrawing support for future contracts can influence published findings.8 Meanwhile, 
donors are under intense pressure to demonstrate that their ‘investments’ deliver results. As such, it 
can be difficult for all parties to withstand the pressure to contribute to positive bias in support of 
‘success stories’ about programmes and interventions,9 even when the consequence is 
misrepresentation of what is working and how public funds are used.  
Necessary changes to protect researchers’ independence 
Uninhibited debate on the behind-the-scenes dynamics of research and evaluation is overdue. Both 
structural and cultural changes are needed to confront what has recently been called the “success 
cartel” in global health,10 and to prevent external actors’ manipulation of university research 
regulations to control what are not solely ‘ethical’ but also political issues.  
DFID is a leading global health funder, which, despite the challenges we have experienced, is notable 
for committing significant resources to generating learning from its programmes, including in 
controversial areas that other donors avoid. Yet DFID and other donors must be clearer towards 
implementing partners that, no matter how sensitive the topic, they will be subject to independent 
evaluation that will be made public.  
Better systems for redress are necessary for researchers whose independence is threatened, 
particularly in the ethically hazy area of ‘evaluation research’ where the political economy of the 
evaluation process can have such a distorting effect on findings. This should include fully independent 
research project management committees that can arbitrate conflicts of interest, as exist for clinical 
trials. Universities should expand the remit of existing committees, establish new ones or, ideally, 
appoint an independent ombudsperson to consider how to better balance protection of organisations’ 
interests and the public interest,11 as specified in the UK Economic and Social Research Council ethical 
guidance.12   
Ultimately, universities have a duty to contribute evidence to public policy-making and to protect 
academic integrity. Fulfilling this duty will depend not only on stronger research governance 
frameworks to safeguard independence, but also on directly challenging the power of external donors 
that enables them to interfere in the research process. 
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